Amanda Fitzpatrick

5PUBLICATIONS
32CO-AUTHORS
Predictive and prognostic markersMolecular targetsOther biomedical and clinical sciences not elsewhere classifiedHaematological tumoursSolid tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Oct 13, 2026
Cerebrospinal fluid and plasma circulating tumor DNA dynamics as a biomarker of response during trastuzumab deruxtecan treatment in patients with breast cancer with leptomeningeal disease.

|Oct 16, 2024
Chondroitin Sulfate Proteoglycan 4 (CSPG4) as an Emerging Target for Immunotherapy to Treat Melanoma.

Xinyi Chen, Shabana Habib, Madalina Alexandru

|Aug 02, 2024
BMScope: A scoping review to chart the evolving clinical study landscape in brain and leptomeningeal metastasis.

Vinton W T Cheng, Richard Heywood, Rasheed Zakaria

|Nov 17, 2023
Genomic profiling and pre-clinical modelling of breast cancer leptomeningeal metastasis reveals acquisition of a lobular-like phenotype.

Amanda Fitzpatrick, Marjan Iravani, Adam Mills

|Nov 09, 2019
Controversial issues in the neoadjuvant treatment of triple-negative breast cancer.

Amanda Fitzpatrick, Andrew Tutt

Pageof 1

Frequent Collaborators

2 joint publications

Andrew Tutt

2 joint publications

Marjan Iravani

2 joint publications

Syed Haider

1 joint publications

Adam Mills